New combo drug CagriSema shows promise in cutting appetite and food intake
NCT ID NCT06207877
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 17 times
Summary
This study looked at whether CagriSema, a combination of two medicines, can lower how much people eat and their appetite. 62 adults with overweight or obesity received either CagriSema or a placebo for about 32 weeks. Researchers measured food intake and stomach emptying to see if the drug helps control eating behavior.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel International GmbH
Berlin, 14050, Germany
Conditions
Explore the condition pages connected to this study.